LeanLife Health Inc.
LNLHF · OTC
12/31/2021 | 9/30/2021 | 6/30/2021 | 3/31/2021 | |
|---|---|---|---|---|
| Valuation | ||||
| PEG Ratio | 0.30 | 1.05 | 0.10 | 0.13 |
| FCF Yield | 0.70% | -2.17% | -2.91% | -2.37% |
| EV / EBITDA | -9.90 | -22.59 | -16.38 | -13.52 |
| Quality | ||||
| ROIC | 105.09% | 205.18% | -387.86% | -170.40% |
| Gross Margin | 0.00% | 0.00% | 0.00% | 0.00% |
| Cash Conversion Ratio | -0.09 | 0.61 | 0.55 | 0.22 |
| Growth | ||||
| Revenue 3-Year CAGR | -100.00% | -100.00% | -100.00% | -100.00% |
| Free Cash Flow Growth | 114.12% | -0.04% | 10.57% | 40.54% |
| Safety | ||||
| Net Debt / EBITDA | -0.20 | -0.30 | -0.27 | 0.01 |
| Interest Coverage | -190.71 | -138.18 | -166.40 | -167.89 |
| Efficiency | ||||
| Inventory Turnover | 0.00 | 0.00 | 0.00 | 0.00 |
| Cash Conversion Cycle | -153,586.85 | -50,018.29 | -9,603.18 | -69,800.08 |